Items where Subject is "Diabetes Clinical Trials > Lipid Lowering Drugs"
Group by: Creators | Item Type
Number of items at this level: 6.
Gokulakrishnan, K and Aravindhan, V and Amutha, A and Abhijit, S and Ranjani, H and Anjana, R M and Unnikrishnan, R and Miranda, P and Narayan, K M V and Mohan, V (2013) Serum Adiponectin Helps to Differentiate Type 1 and Type 2 Diabetes Among Young Asian Indians. Diabetes Technology & Therapeutics, 15 (8). p. 695. ISSN 1520-9156
Jayashree, B and Bibin, Y S and Prabhu, D and Shanthirani, C S and Gokulakrishnan, K and Lakshmi, B S and Mohan, V and Balasubramanyam, M (2014) Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Molecular and Cellular Biochemistry, 388 (1-2). p. 203. ISSN 0300-8177
Poongothai, S and Karkuzhali, K and Siva Prakash, G and Sangaatha, T and Saravanan, T and Deepa, R and Sharada, G and Mohan, V (2005) Effect of essentiale in diabetic subjects with Non - Effect of essentiale in diabetic subjects with Non - Alcoholic fatty liver. International Journal of Diabetes in Developing Countries, 25 (1). pp. 12-9.
Rajmohan, L and Mohan, V (2001) postprandial hyperlipidemia & hyperlipidemia. Japi, 49 . pp. 19-21.
Rema, M and Srivastava, B K and Anitha, B and Deepa, R and Mohan, V (2006) Association of serum lipids with diabetic retinopathy in urban South Indians—the Chennai Urban Rural Epidemiology Study (CURES) Eye Study—2. Diabetic Medicine, 23 (9). pp. 1029-36. ISSN 0742-3071
The ORIGIN Trial, Study (2008) Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). American Heart Journal, 155 (1). 26.e1. ISSN 00028703